梅州普通怀孕无痛人流要多少钱-【梅州曙光医院】,梅州曙光医院,梅州妇科好的医院有哪家,梅州患了慢性淋菌性尿道炎该怎么办,梅州韩式隆鼻美容,梅州妇科 哪个医院好,梅州得了慢性宫颈炎怎么治,梅州中度宫颈糜烂怎么治

BEIJING, Sept. 20 (Xinhua) -- Floods and landslides triggered by recent heavy rains in eight of China's provincial-level regions have left 70 people dead and 32 others missing this month.Heavy downpours, floods and other related disasters have affected Sichuan, Shaanxi, Henan, Chongqing, Hubei, Shandong, Shanxi and Gansu, the National Disaster Reduction Commission said in a statement released on Tuesday.As of Tuesday, these disasters have affected 21.56 million people and caused an estimated 26.09 billion yuan (4.08 billion U.S. dollars) in direct economic losses, the statement said.
WASHINGTON, Sept. 15 (Xinhua) -- The rates of new lung cancer cases in the United States dropped among men in 35 states and among women in six states between 1999 and 2008, according to a report released Thursday by the Centers for Disease Control and Prevention (CDC).Among women, lung cancer incidence decreased nationwide between 2006 and 2008, after increasing steadily for decades.The decrease in lung cancer cases corresponds closely with smoking patterns across the nation, the report said. In the West, where smoking prevalence is lower among men and women than in other regions, lung cancer incidence is decreasing faster. Studies show declines in lung cancer rates can be seen as soon as five years after smoking rates decline.The report also noted that states that make greater investments in effective tobacco control strategies see larger reductions in smoking; and the longer they invest, the greater the savings in smoking -- related health care costs. Such strategies include higher tobacco prices, hard-hitting media campaigns, 100 percent smoke-free policies, and easily accessible quitting treatments and services for those who want to quit."Although lung cancer among men and women has decreased over the past few years," said CDC Director Thomas Frieden in a statement. "too many people continue to get sick and die from lung cancers, most of which are caused by smoking. The more we invest in proven tobacco control efforts, the fewer people will die from lung cancer."Lung cancer is the most commonly diagnosed cancer, and the leading cause of cancer death in the United States. Cigarette smoking and exposure to secondhand smoke cause most lung cancer deaths in the United States.

BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."
来源:资阳报